Antidepressant treatment and adherence to antiretroviral medications among privately insured persons with HIV/AIDS

AIDS and Behavior

Volumn 15, Issue 8, 2011, Pages 1819-1828

  Akincigil, Ayse ^a,b   Wilson, Ira B ^c   Walkup, James T ^b,d   Siegel, Michele J ^b   Huang, Cecilia ^b   Crystal, Stephen ^a  

^a RUTGERS UNIVERSITY   (United States)

^b The State University of New Jersey   (United States)

^c BROWN UNIVERSITY   (United States)

^d RUTGERS UNIVERSITY   (United States)

Author keywords

Adherence; Antidepressant; Depression; Private insurance; Psychotherapy

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIRETROVIRUS AGENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; DEPRESSION; FEMALE; HEALTH INSURANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSURANCE; MALE; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; RETROSPECTIVE STUDY; STATISTICAL MODEL;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTI-RETROVIRAL AGENTS; ANTIDEPRESSIVE AGENTS; DEPRESSION; FEMALE; HIV INFECTIONS; HUMANS; INSURANCE CLAIM REVIEW; INSURANCE, HEALTH; LOGISTIC MODELS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PRIVATE SECTOR; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84555208317     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-011-9938-6     Document Type: Article

References (61)

1. Egede LE, Zheng D, Simpson K. Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care. 2002;25:464-70. (Pubitemid 41103337)
2. Katon W, Lin EH, Kroenke K. The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen Hosp Psychiatry. 2007;29:147-55.
3. Koenig HG. Depression in hospitalized older patients with congestive heart failure. Gen Hosp Psychiatry. 1998;20:29-43. (Pubitemid 28109986)
4. Schmitz N, Wang J, Malla A, Lesage A. Joint effect of depression and chronic conditions on disability: Results from a populationbased study. Psychosom Med. 2007;69:332-8. (Pubitemid 46800293)
5. Bayliss EA, Steiner JF, Fernald DH, Crane LA, Main DS. Descriptions of barriers to self-care by persons with comorbid chronic diseases. Ann Fam Med. 2003;1:15-21.
6. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487-97. (Pubitemid 41127293)
7. Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi A. Improving chronic illness care: Translating evidence into action. Health Aff (Millwood). 2001;20:64-78. (Pubitemid 33707442)
8. Butters MA, Becker JT, Nebes RD, et al. Changes in cognitive functioning following treatment of late-life depression. Am J Psychiatry. 2000;157:1949-54.
9. Norwood R. Prevalence and impact of depression in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med. 2006;12:113-7. (Pubitemid 44384785)
10. Schweitzer RD, Head K, Dwyer JW. Psychological factors and treatment adherence behavior in patients with chronic heart failure. J Cardiovasc Nurs. 2007;22:76-83.
11. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160:2101-7. (Pubitemid 30482715)
12. Cruess DG, Evans DL, Repetto MJ, Gettes D, Douglas SD, Petitto JM. Prevalence, diagnosis, and pharmacological treatment of mood disorders in HIV disease. Biol Psychiatry. 2003;54: 307-16. (Pubitemid 37267860)
13. Bing EG, Burnam MA, Longshore D, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry. 2001;58:721-8. (Pubitemid 32717795)
14. Gifford AL, Bormann JE, Shively MJ, Wright BC, Richman DD, Bozzette SA. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. J Acquir Immune Defic Syndr. 2000;23:386-95. (Pubitemid 30431595)
15. Bangsberg DR, Perry S, Charlebois ED, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15:1181-3. (Pubitemid 32549871)
16. Harrigan PR, Hogg RS, Dong WW, et al. Predictors of HIV drugresistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy. J Infect Dis. 2005;191:339-47. (Pubitemid 40139758)
17. Bangsberg DR, Acosta EP, Gupta R, et al. Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness. AIDS. 2006;20: 223-31.
18. Maggiolo F, Airoldi M, Kleinloog HD, et al. Effect of adherence to HAART on virologic outcome and on the selection of resistance- conferring mutations in NNRTI- or PI-treated patients. HIV Clin Trials. 2007;8:282-92. (Pubitemid 350099562)
19. Hammer SM, Eron JJ Jr, Reiss P, et al. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA. 2008;300:555-70.
20. Battaglioli-DeNero AM. Strategies for improving patient adherence to therapy and long-term patient outcomes. J Assoc Nurses AIDS Care. 2007;18:S17-22.
21. Nachega JB, Trotta MP, Nelson M, Ammassari A. Impact of metabolic complications on antiretroviral treatment adherence: Clinical and public health implications. Curr HIV/AIDS Rep. 2009;6:121-9.
22. Schonnesson LN, Williams ML, Ross MW, Diamond PM, Keel B. Three types of adherence to HIV antiretroviral therapy and their association with AIDS diagnosis, medication side-effects, beliefs about antiretroviral therapy, and beliefs about HIV disease. Int J STD AIDS. 2007;18:369-73. (Pubitemid 351738975)
23. Bouhnik AD, Preau M, Vincent E, et al. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy. Antivir Ther. 2005;10:53-61. (Pubitemid 40767631)
24. Horberg MA, Silverberg MJ, Hurley LB, et al. Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. J Acquir Immune Defic Syndr. 2008;47:384-90. (Pubitemid 351619427)
25. Kacanek D, Jacobson DL, Spiegelman D, Wanke C, Isaac R, Wilson IB. Incident depression symptoms are associated with poorer HAART adherence: A longitudinal analysis from the Nutrition for Healthy Living study. J Acquir Immune Defic Syndr. 2010;53:266-72.
26. Kleeberger CA, Phair JP, Strathdee SA, Detels R, Kingsley L, Jacobson LP. Determinants of heterogeneous adherence to HIVantiretroviral therapies in the multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr. 2001;26:82-92. (Pubitemid 32115053)
27. Laine C, Newschaffer CJ, Zhang D, Cosler L, Hauck WW, Turner BJ. Adherence to antiretroviral therapy by pregnant women infected with human immunodeficiency virus: A pharmacy claims-based analysis. Obstet Gynecol. 2000;95:167-73. (Pubitemid 30045634)
28. Simoni JM, Frick PA, Lockhart D, Liebovitz D. Mediators of social support and antiretroviral adherence among an indigent population in New York City. AIDS Patient Care STDS. 2002;16:431-9.
29. Singh N, Squier C, Sivek C, Wagener M, Nguyen MH, Yu VL. Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: Prospective assessment with implications for enhancing compliance. AIDS Care. 1996;8:261-9. (Pubitemid 26164414)
30. Starace F, Ammassari A, Trotta MP, et al. Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2002;31(Suppl 3):S136-9. (Pubitemid 35453574)
31. Turner BJ, Laine C, Cosler L, Hauck WW. Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users. J Gen Intern Med. 2003;18:248-57. (Pubitemid 36529041)
32. Walkup J, Wei W, Sambamoorthi U, Crystal S. Antidepressant treatment and adherence to combination antiretroviral therapy among patients with AIDS and diagnosed depression. Psychiatr Q. 2008;79:43-53.
33. Ferrando SJ, Freyberg Z. Treatment of depression in HIV positive individuals: A critical review. Int Rev Psychiatry. 2008;20:61-71. (Pubitemid 351196202)
34. Ferrando SJ, Goldman JD, Charness WE. Selective serotonin reuptake inhibitor treatment of depression in symptomatic HIV infection, AIDS. Improvements in affective and somatic symptoms. Gen Hosp Psychiatry. 1997;19:89-97. (Pubitemid 27146816)
35. Ferrando SJ, Wapenyi K. Psychopharmacological treatment of patients with HIV and AIDS. Psychiatr Q. 2002;73:33-49. (Pubitemid 38529090)
36. Rabkin JG. HIV and depression: 2008 review and update. Curr HIV/AIDS Rep. 2008;5:163-71.
37. Imel ZE, Malterer MB, McKay KM, Wampold BE. A metaanalysis of psychotherapy and medication in unipolar depression and dysthymia. J Affect Disord. 2008;110:197-206.
38. Safren S, Hendriksen E, Mayer K, et al. Cognitive-behavioral therapy for HIV medication adherence and depression. Cogn Behav Pract. 2004;11:415-24. (Pubitemid 43225380)
39. Safren SA, O'Cleirigh C, Tan JY, et al. A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals. Health Psychol. 2009;28:1-10.
40. Centers for Disease Control and Prevention. HIV/AIDS surveillance report. Rev. ed. Atlanta: U.S. Department of Health and Human Services; 2007.
41. Crystal S, Akincigil A, Sambamoorthi U, et al. The diverse older HIV-positive population: A national profile of economic circumstances, social support, and quality of life. J Acquir Immune Defic Syndr. 2003;33(Suppl 2):S76-83. (Pubitemid 36801605)
42. Shapiro MF, Morton SC, McCaffrey DF, et al. Variations in the care of HIV-infected adults in the United States: Results from the HIV cost and services utilization Study. JAMA. 1999;281: 2305-15. (Pubitemid 29289823)
43. Kaiser Family Foundation. Financing HIV/AIDS care: A quilt with many holes. In: HIV/AIDS Policy Issue Brief; 2004. http://www.kff.org/hivaids/upload/ Financing-HIV-AIDS-Care-AQuilt- with-Many-Holes.pdf. Accessed 15 Feb 2011.
44. Weaver MR, Conover CJ, Proescholdbell RJ, Arno PS, Ang A, Ettner SL. Utilization of mental health and substance abuse care for people living with HIV/AIDS, chronic mental illness, and substance abuse disorders. J Acquir Immune Defic Syndr. 2008;47:449-58. (Pubitemid 351366964)
45. Walkup JT, Wei W, Sambamoorthi U, Crystal S. Sensitivity of an AIDS case-finding algorithm: Who are we missing? Med Care. 2004;42:756-63.
46. Wilson IB, Tchetgen E, Spiegelman D. Patterns of adherence with antiretroviral medications: An examination of between-medication differences. JAcquir Immune Defic Syndr. 2001;28:259-63. (Pubitemid 33061621)
47. Crepaz N, Passin WF, Herbst JH, et al. Meta-analysis of cognitive- behavioral interventions on HIV-positive persons' mental health and immune functioning. Health Psychol. 2008;27:4-14. (Pubitemid 351217074)
48. Himelhoch S, Medoff DR, Oyeniyi G. Efficacy of group psychotherapy to reduce depressive symptoms among HIV-infected individuals: A systematic review and meta-analysis. AIDS Patient Care STDS. 2007;21:732-9. (Pubitemid 47614389)
49. Arean PA, Cook BL. Psychotherapy and combined psychotherapy/ pharmacotherapy for late life depression. Biol Psychiatry. 2002;52:293-303. (Pubitemid 35232095)
50. Cuijpers P, van Straten A, Warmerdam L, Andersson G. Psychotherapy versus the combination of psychotherapy and pharmacotherapy in the treatment of depression: A meta-analysis. Depress Anxiety. 2009;26:279-88.
51. Markowitz JC, Kocsis JH, Fishman B, et al. Treatment of depressive symptoms in human immunodeficiency virus-positive patients. Arch Gen Psychiatry. 1998;55:452-7. (Pubitemid 28237279)
52. Becker SL, Dezii CM, Burtcel B, Kawabata H, Hodder S. Young HIV-infected adults are at greater risk for medication nonadherence. MedGenMed. 2002;4:21.
53. Berg KM, Demas PA, Howard AA, Schoenbaum EE, Gourevitch MN, Arnsten JH. Gender differences in factors associated with adherence to antiretroviral therapy. J Gen Intern Med. 2004;19: 1111-7. (Pubitemid 39552581)
54. Golin CE, Liu H, Hays RD, et al. A prospective study of predictors of adherence to combination antiretroviral medication. J Gen Intern Med. 2002;17:756-65. (Pubitemid 35286241)
55. Yun LW, Maravi M, Kobayashi JS, Barton PL, Davidson AJ. Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients. J Acquir Immune Defic Syndr. 2005;38:432-8. (Pubitemid 40381553)
56. Wilson IB, Jacobson D. Regarding: "Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients". J Acquir Immune Defic Syndr. 2006;41: 254-5. author reply 255.
57. Vitiello B, Burnam MA, Bing EG, Beckman R, Shapiro MF. Use of psychotropic medications among HIV-infected patients in the United States. Am J Psychiatry. 2003;160:547-54. (Pubitemid 41094264)
58. Olfson M, Marcus SC. National patterns in antidepressant medication treatment. Arch Gen Psychiatry. 2009;66:848-56.
59. Grymonpre R, Cheang M, Fraser M, Metge C, Sitar DS. Validity of a prescription claims database to estimate medication adherence in older persons. Med Care. 2006;44:471-7. (Pubitemid 43755427)
60. Nachega JB, Hislop M, Dowdy DW, et al. Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults. J Acquir Immune Defic Syndr. 2006;43:78-84. (Pubitemid 44306492)
61. Acri T, TenHave TR, Chapman JC, Bogner HR, Gross R. Lack of association between retrospectively collected pharmacy refill data and electronic drug monitoring of antiretroviral adherence. AIDS Behav. 2008;14:748-54.